Myelosis Radiation

Radiation myelosis

A cute word with an English language and an eerie meaning - “Radial myositis” or “Articular myilitis”, as radial myosytopenia was also called in Russian literature. What is it? The root of this word lies in the translation of the word Radialis from the Latin radius ("ray"); this method was named so because its application is based on the effect of x-rays. It is worth noting that this disease can occur as a result of radiation therapy. Treatment involves reducing the radiation dose. An important role is played by symptomatic treatment and the use of non-steroidal anti-inflammatory drugs. It often happens that with age, therapy does not bring the desired result - the disease goes away when the radiation dose to the patient decreases. In this case, doctors suggest directing the radiation “tangentially” (segmentally) to the spine and muscle tissue. However, given the high dependence of changes in the radiation dose on the age and weight of the patient, the dose “prescribed” throughout life often leads to a person’s retirement. Many authors draw attention to this as “the main damage associated with exposure to radiation - damage to the musculoskeletal system.”

Treatment. During periods of exacerbations, **painkillers** are indicated in the form of tablets (analgin, etc.), possibly with the addition of antispasmodics ("no-shpa", papaverine). In the first days, you can prescribe **tablets containing corticosteroids for an anti-inflammatory effect** - “dexamethasone” (0.5 mg in the morning and 0-1 mg in the evening after meals), along with analgesics. If there is an active development of osteoporosis of the knee and hip joints, the doctor prescribes **non-steroidal anti-inflammatory drugs** from intra-articular injection (according to the level of the lesion). Of these, Movalis is the safest and most effective; it is injected directly into the joint, acts for several days and leaves through the bloodstream (through the kidneys), without giving the side effects inherent, for example, in Diclofenac. The advantage of Movalis is that, unlike, for example, Teraflex or Chondroitin, in this situation it remains intramuscular and gives positive dynamics within 24 hours. This is the main achievement that puts Movalis above other drugs; today it is the main drug in the treatment of osteoporosis." I would also like to note an interesting fact that few know about: "Until very recently, clinical trials of new drugs were banned in Russia drugs, and Movalis appeared on the market immediately with instructions that corresponded only to the state of affairs that existed at the time of its creation. Today it is already obvious that the course of treatment with “Menovazin” is more dangerous for older people.” These words are an excellent illustration of how sometimes inappropriately a “translator” can be useful in our country: a doctor who listens to a patient or gathers a consultation must have various knowledge.

An unwelcoming world